Traditional Chinese Medicine for Coronary Heart Disease: Clinical Evidence and Possible Mechanisms
Coronary heart disease (CHD) remains a major cause of mortality with a huge economic burden on healthcare worldwide. Here, we conducted a systematic review to investigate the efficacy and safety of Chinese herbal medicine (CHM) for CHD based on high-quality randomized controlled trials (RCTs) and su...
Saved in:
Main Authors: | Ke-Jian Zhang (Author), Qun Zheng (Author), Peng-Chong Zhu (Author), Qiang Tong (Author), Zhuang Zhuang (Author), Jia-Zhen Zhu (Author), Xiao-Yi Bao (Author), Yue-Yue Huang (Author), Guo-Qing Zheng (Author), Yan Wang (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2019-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Shexiang Baoxin Pills for Coronary Heart Disease in Animal Models: Preclinical Evidence and Promoting Angiogenesis Mechanism
by: Ke-Jian Zhang, et al.
Published: (2017) -
Danshensu for Myocardial Ischemic Injury: Preclinical Evidence and Novel Methodology of Quality Assessment Tool
by: Xiao-yi Bao, et al.
Published: (2018) -
Ligustrazine Exerts Cardioprotection in Animal Models of Myocardial Ischemia/Reperfusion Injury: Preclinical Evidence and Possible Mechanisms
by: Qun Zheng, et al.
Published: (2018) -
Protective Effect and Possible Mechanisms of Astragaloside IV in Animal Models of Diabetic Nephropathy: A Preclinical Systematic Review and Meta-Analysis
by: Hong Wang, et al.
Published: (2020) -
Notoginsenoside R1 for Organs Ischemia/Reperfusion Injury: A Preclinical Systematic Review
by: Qiang Tong, et al.
Published: (2019)